Tailored treatment tested to boost survival for older leukemia patients
NCT ID NCT03226418
Summary
This study tested a personalized approach to treat acute myeloid leukemia (AML) in adults aged 60 and older. Doctors assigned patients to either strong or milder chemotherapy based on their genetic risk and a detailed health assessment. The goal was to see if this tailored strategy could improve survival and quality of life compared to standard approaches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SECONDARY ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Conditions
Explore the condition pages connected to this study.